What is GeniPhys?
GeniPhys is at the forefront of developing and commercializing advanced collagen materials designed for custom applications. Their innovative approach aims to accelerate and enhance tissue restoration and regeneration processes. Based in Zionsville, Indiana, the company's proprietary collagen technology supports custom design and fabrication, offering a significant advantage in the regenerative medicine market. The company's focus on custom solutions positions it to address a wide range of therapeutic needs.
How much funding has GeniPhys raised?
GeniPhys has raised a total of $9M across 2 funding rounds:
Series A
$6M
Private Equity
$3M
Series A (2023): $6M with participation from Elevate Ventures and Pier 70 Ventures
Private Equity (2026): $3M, investors not publicly disclosed
Key Investors in GeniPhys
Elevate Ventures
Elevate Ventures is an active participant in shaping the future of Indiana by investing in cross-sector innovation-driven companies at Pre-Seed, Seed, and Series A stages. They provide funding and guidance for entrepreneurs and seek founders with grit, creativity, and coachability. Elevate Ventures sources founders with great ideas, validates pain points, and provides initial guidance to obtain capital.
Pier 70 Ventures
Pier 70 Ventures invests in talented entrepreneurs who are driving innovation and pushing humanity forward. They focus on impact-driven technologies, particularly in healthcare, and provide capital, mentorship, and access to a global network to accelerate high-growth sustainable companies. The firm emphasizes building diverse teams and enhancing governance to achieve financial success for their portfolio companies. Their approach combines deep investment experience with a commitment to supporting entrepreneurs, ultimately aiming for superior financial returns and collective value creation.
What's next for GeniPhys?
With this substantial enterprise-level funding, GeniPhys is poised for significant expansion and further research and development. The strategic investment will likely fuel the scaling of its manufacturing capabilities and the advancement of its product pipeline. Future growth may involve broader clinical trials, strategic partnerships with healthcare providers, and the expansion into new therapeutic areas. The company's trajectory suggests a strong focus on market penetration and establishing itself as a leader in custom collagen-based regenerative therapies.
See full GeniPhys company page
